当前位置: X-MOL 学术Depression Anxiety › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
At baseline patients treated with esketamine have higher burden of disease than other patients with treatment resistant depression: Learnings from a population based study
Depression and Anxiety ( IF 4.7 ) Pub Date : 2021-01-21 , DOI: 10.1002/da.23138
M Soledad Cepeda 1 , David M Kern 1 , Carla M Canuso 2
Affiliation  

It is critical to assess who is being treated with a new marketed drug like esketamine to understand how it is used in the real‐world setting and the effects of the medication.

中文翻译:

在基线时,使用艾氯胺酮治疗的患者比其他具有抗药性抑郁症的患者具有更高的疾病负担:基于人群的研究

评估谁正在使用新上市药物如esketamine进行治疗,了解其在现实环境中的使用方式以及药物的作用,这一点至关重要。
更新日期:2021-01-21
down
wechat
bug